<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0400">
 <label>80</label>
 <element-citation publication-type="book" id="rf0385">
  <person-group person-group-type="author">
   <name>
    <surname>Chen</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Gong</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>X.</given-names>
   </name>
  </person-group>
  <chapter-title>First Clinical Study Using HCV Protease Inhibitor Danoprevir to Treat Naive and Experienced COVID-19 Patients</chapter-title>
  <year>2020</year>
 </element-citation>
</ref>
